(Q48970248)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21045078%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

editorial

0 references

title

Diabesity: an overview of a rising epidemic (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21045078%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21045078%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Mahmoud R Gaballa

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21045078%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

2 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21045078%20AND%20SRC:MED&resulttype=core&format=json

Nephrology Dialysis Transplantation

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21045078%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21045078%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21045078%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

28-35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21045078%20AND%20SRC:MED&resulttype=core&format=json

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Diabesity: An Inflammatory Metabolic Condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

The epidemiology of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Global and societal implications of the diabetes epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Epigenetics: a molecular link between environmental factors and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

A genome-wide association study identifies novel risk loci for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Global estimates of the prevalence of diabetes for 2010 and 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Prevalence of diabetes among men and women in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Epidemic obesity and type 2 diabetes in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Is there a link between components of health-related functioning and incident impaired glucose metabolism and type 2 diabetes? The Australian Diabetes Obesity and Lifestyle (AusDiab) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Diabetes and its impact on health-related quality of life: a life table analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Global healthcare expenditure on diabetes for 2010 and 2030.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

The global cost of nonoptimal blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Prevalence and trends in obesity among US adults, 1999-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Predicting obesity in young adulthood from childhood and parental obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Genetic study of the height and weight process during infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Impact of overweight on the risk of developing common chronic diseases during a 10-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

The effect of obesity on quality of life in patients with diabetes and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

The cost of lifestyle health risks: obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Impact of morbid obesity on medical expenditures in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Annual medical spending attributable to obesity: payer-and service-specific estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Indirect costs of obesity: a review of the current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Association of depression with newly diagnosed type 2 diabetes among adults aged between 25 to 60 years in Karachi, Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Screening for diabetes in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Screening for obesity in adults: recommendations and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

A1C for screening and diagnosis of type 2 diabetes in routine clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Innate immunity, insulin resistance and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Direct and macrophage-mediated actions of fatty acids causing insulin resistance in muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Diabesity: therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Efficacy and tolerability of vildagliptin monotherapy in drug-naïve patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Liraglutide: a once-daily GLP-1 analogue for the treatment of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled tr

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Drug treatments for obesity: orlistat, sibutramine, and rimonabant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Health-economic burden of obesity in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Economic costs of obesity and inactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

The burden of coronary, cerebrovascular and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576

Obesity in Europe: prevalence and consequences for use of medical care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ576